Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pneumonia V: Nursing management and Prevention

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...

Pneumonia III: Complications and Assessment

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:

Pneumonia IV: Management

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

Pneumonia II: Pathophysiology

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:

Acute Pharyngitis

Acute Pharyngitis

Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Ultrasound dynamics during treatment of pulmonary and extra-pulmonary TB.

IJTLD open·2026

Same author

Vaccine Nation: How Immunization Shaped India : Ameer Shahul, Pan Macmillian India, Pages 478, Price Rs. 699/.

Indian pediatrics·2026

Same author

Adrenal Insufficiency after Steroid Therapy in Children with Steroid-Sensitive Nephrotic Syndrome: A Cross-sectional Study.

Indian journal of endocrinology and metabolism·2025

Same author

What are the 100 most cited fungal genera?

Studies in mycology·2024

Same author

Quality of Life of Developmentally Normal Children With Epilepsy and Their Siblings.

Cureus·2023

Same author

USPSTF and ISPAD Guidelines on Screening for Prediabetes and Type 2 Diabetes in Children and Adolescents.

Indian pediatrics·2023

Search research articles

Related Experiment Video

Updated: Feb 23, 2026

Capsular Serotyping of Streptococcus pneumoniae Using the Quellung Reaction

Capsular Serotyping of Streptococcus pneumoniae Using the Quellung Reaction

Published on: February 24, 2014

Pneumococcal Vaccines - How Many Serotypes are Enough?

Aaradhana Singh¹, A K Dutta²

¹Department of Pediatrics, University College of Medical Sciences and Guru Tegh Bahadur Hospital, New Delhi, India. draaradhanasingh@gmail.com.

Indian Journal of Pediatrics

|September 10, 2017

Summary

Pneumococcal vaccines, like PCV13, are crucial for reducing childhood illness and mortality in India. Evaluating available vaccines based on efficacy, cost, and safety is essential for national immunization programs.

Keywords:

Invasive pneumococcal disease (IPD)National immunization programme (NIP)Pneumococcal conjugate vaccine (PCV)

More Related Videos

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43

Published on: September 11, 2020

Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination

Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination

Published on: September 25, 2014

Related Experiment Videos

Last Updated: Feb 23, 2026

Capsular Serotyping of Streptococcus pneumoniae Using the Quellung Reaction

Capsular Serotyping of Streptococcus pneumoniae Using the Quellung Reaction

Published on: February 24, 2014

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43

Published on: September 11, 2020

Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination

Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination

Published on: September 25, 2014

Area of Science:

Medical Microbiology
Vaccinology
Public Health

Background:

Streptococcus pneumoniae causes severe diseases including meningitis and pneumonia, particularly in children and the elderly.
It is a major contributor to under-five mortality and morbidity globally and in India.
Pneumococcal vaccines are the most effective intervention to reduce disease burden and mortality.

Purpose of the Study:

To review the available pneumococcal vaccines in India.
To compare their serotype coverage, efficacy, cost-effectiveness, and safety.
To inform the inclusion of Pneumococcal Conjugate Vaccines (PCV) into India's National Immunization Programme (NIP).

Main Methods:

Comparative analysis of available pneumococcal vaccines.
Review of scientific literature on vaccine efficacy, safety, and cost-effectiveness.
Assessment of serotype coverage relevant to India.

Main Results:

Pneumococcal Conjugate Vaccines (PCV) are recommended for inclusion in national immunization programs.
PCV13 inclusion in India's NIP is a recent development.
Vaccine superiority is determined by serotype coverage, efficacy, cost, and safety.

Conclusions:

Pneumococcal vaccination is vital for reducing disease burden and under-five mortality in India.
Further research is needed to understand disease burden and develop vaccines with broader serotype coverage.
Informed vaccine selection is critical for effective public health interventions.